Last reviewed · How we verify

NCT05595070: RadboudStem

Oral Complications After Haematopoietic Stem Cell Transplantation: a Retrospective Study

Status unknown Last updated 26 October 2022
What this trial tests

trial testing Haematopoietic stem cell transplantation in Stem Cell Transplant Complications in 200 participants. Status unknown.

Timeline
1 April 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorRadboud University Medical Center
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date1 April 2022
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Radboud University Medical Center

Who can join

18 and older, any sex, with Stem Cell Transplant Complications or Oral Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Haematopoietic stem cell transplantation (HSCT) is a potentially lifesaving treatment option for various diseases. It involves infusion of stem cells after a conditioning regimen of chemotherapy with or without total body irradiation. There is a concern that HSCT and accompanying treatments may increase the risk for oral complications. Nevertheless, longitudinal studies measuring oral health before and after HSCT are scarce. Hence, we formulated the following research question: In adult HSCT recipients, do oral health parameters change from baseline (pre-HSCT) to 3 - 24 months post-HSCT, and is the type of conditioning regimen associated with this change in oral health parameters? To answer this research question, we will use data from the electronic health records of the Radboudumc (Epic and Dentium). We will include at least seventy-five adult patients who are examined both before and after HSCT at the department of Dentistry (Radboudumc) as part of an oral care program. The following oral health parameters were assessed: status praesens, pocket probing depth, bleeding on probing, periodontal epithelial surface area, periodontal inflamed surface area, xerostomia, unstimulated and stimulated salivary flow rate and pH, cariesactivity, oral chronic Graft-versus-Host Disease and dental treatments. Patients were subjected to different regimens in preparation for HSCT, namely myeloablative, reduced intensity or non-myeloablative conditioning. To estimate the association between conditioning regimen and the change in oral health parameters, we will use mixed effects models with random effects, adjusted for potential confounders. Results will be reported as regression coefficients with corresponding 95% confidence intervals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Periodontal changes after haematopoietic cell transplantation and the role of conditioning regimen intensity.
    van Gennip LLA, Bulthuis MS, Hannink G, Bronkhorst EM, et al · · 2025 · PMID 40548989 · DOI 10.1007/s00520-025-09654-9

Verify or expand the search:

Other recruiting trials for Stem Cell Transplant Complications

Currently open trials in the same condition.

Other Radboud University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05595070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing